-
1
-
-
37749025593
-
Atopic dermatitis
-
Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483-94
-
(2008)
N Engl J Med
, vol.358
, pp. 1483-1494
-
-
Bieber, T.1
-
2
-
-
26844448558
-
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344
-
Brodmerkel CM, Huber R, Covington M et al. (2005) Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 175:5370-8 (Pubitemid 41456423)
-
(2005)
Journal of Immunology
, vol.175
, Issue.8
, pp. 5370-5378
-
-
Brodmerkel, C.M.1
Huber, R.2
Covington, M.3
Diamond, S.4
Hall, L.5
Collins, R.6
Leffet, L.7
Gallagher, K.8
Feldman, P.9
Collier, P.10
Stow, M.11
Gu, X.12
Baribaud, F.13
Shin, N.14
Thomas, B.15
Burn, T.16
Hollis, G.17
Yeleswaram, S.18
Solomon, K.19
Friedman, S.20
Wang, A.21
Xue, C.B.22
Newton, R.C.23
Scherle, P.24
Vaddi, K.25
more..
-
3
-
-
44049100797
-
Th17 cells: A new fate for differentiating helper T cells
-
Chen Z, O'Shea JJ (2008) Th17 cells: a new fate for differentiating helper T cells. Immunol Res 41:87-102
-
(2008)
Immunol Res
, vol.41
, pp. 87-102
-
-
Chen, Z.1
O'Shea, J.J.2
-
4
-
-
67349230808
-
The IL-23/Th17 axis in the immunopathogenesis of psoriasis
-
Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1339-1350
-
-
Di Cesare, A.1
Di Meglio, P.2
Nestle, F.O.3
-
5
-
-
77955898996
-
Efficacy and Tolerability of Novel JAK inhibitors in Animal Models of Rheumatoid Arthritis
-
Fridman J, Scherle P, Collins R et al. (2007) Efficacy and Tolerability of Novel JAK inhibitors in Animal Models of Rheumatoid Arthritis. Arthritis and Rheumatism 56:5692
-
(2007)
Arthritis and Rheumatism
, vol.56
, pp. 5692
-
-
Fridman, J.1
Scherle, P.2
Collins, R.3
-
6
-
-
77954531991
-
Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: Preclinical characterization of INCB028050
-
Fridman JS, Scherle PA, Collins R et al. (2010) Selective inhibition of JAK1 and JAK2 is efficacious in rodent models of arthritis: preclinical characterization of INCB028050. J Immunol 184:5298-307
-
(2010)
J Immunol
, vol.184
, pp. 5298-5307
-
-
Fridman, J.S.1
Scherle, P.A.2
Collins, R.3
-
8
-
-
70349241839
-
IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells
-
Goodman WA, Levine AD, Massari JV et al. (2009) IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 183:3170-6
-
(2009)
J Immunol
, vol.183
, pp. 3170-3176
-
-
Goodman, W.A.1
Levine, A.D.2
Massari, J.V.3
-
9
-
-
60249084148
-
Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial
-
Gottlieb A, Menter A, Mendelsohn A et al. (2009) Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 373:633-40
-
(2009)
Lancet
, vol.373
, pp. 633-640
-
-
Gottlieb, A.1
Menter, A.2
Mendelsohn, A.3
-
10
-
-
12144281223
-
Psoriasis: Emerging therapeutic strategies
-
DOI 10.1038/nrd1607
-
Gottlieb AB (2005) Psoriasis: emerging therapeutic strategies. Nat Rev Drug Discov 4:19-34 (Pubitemid 40109587)
-
(2005)
Nature Reviews Drug Discovery
, vol.4
, Issue.1
, pp. 19-34
-
-
Gottlieb, A.B.1
-
11
-
-
0037423763
-
Cloning and characterization of a functional promoter of the human SOCS-3 gene
-
DOI 10.1016/S0006-291X(02)03071-1
-
He B, You L, Uematsu K et al. (2003) Cloning and characterization of a functional promoter of the human SOCS-3 gene. Biochem Biophys Res Commun 301:386-91 (Pubitemid 36279250)
-
(2003)
Biochemical and Biophysical Research Communications
, vol.301
, Issue.2
, pp. 386-391
-
-
He, B.1
You, L.2
Uematsu, K.3
Matsangou, M.4
Xu, Z.5
He, M.6
McCormick, F.7
Jablons, D.M.8
-
12
-
-
40349095005
-
The psychosocial and occupational impact of chronic skin disease
-
DOI 10.1111/j.1529-8019.2008.00170.x
-
Hong J, Koo B, Koo J (2008) The psychosocial and occupational impact of chronic skin disease. Dermatol Ther 21:54-9 (Pubitemid 351342175)
-
(2008)
Dermatologic Therapy
, vol.21
, Issue.1
, pp. 54-59
-
-
Hong, J.1
Koo, B.2
Koo, J.3
-
13
-
-
0029348007
-
The Janus protein tyrosine kinases in hematopoietic cytokine signaling
-
Ihle JN (1995) The Janus protein tyrosine kinases in hematopoietic cytokine signaling. Semin Immunol 7:247-54
-
(1995)
Semin Immunol
, vol.7
, pp. 247-254
-
-
Ihle, J.N.1
-
14
-
-
39649108216
-
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: Results of a randomized, placebo-controlled, phase 2 trial
-
DOI 10.1001/archdermatol.2007.63
-
Kimball AB, Gordon KB, Langley RG et al. (2008) Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial. Arch Dermatol 144:200-7 (Pubitemid 351287002)
-
(2008)
Archives of Dermatology
, vol.144
, Issue.2
, pp. 200-207
-
-
Kimball, A.B.1
Gordon, K.B.2
Langley, R.G.3
Menter, A.4
Chartash, E.K.5
Valdes, J.6
-
15
-
-
43449111187
-
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
-
DOI 10.1016/S0140-6736(08)60725-4, PII S0140673608607254
-
Leonardi CL, Kimball AB, Papp KA et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371: 1665-74 (Pubitemid 351671883)
-
(2008)
The Lancet
, vol.371
, Issue.9625
, pp. 1665-1674
-
-
Leonardi, C.L.1
Kimball, A.B.2
Papp, K.A.3
Yeilding, N.4
Guzzo, C.5
Wang, Y.6
Li, S.7
Dooley, L.T.8
Gordon, K.B.9
-
16
-
-
33344455022
-
Thymic stromal lymphopoietin: Master switch for allergic inflammation
-
Liu YJ (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269-73
-
(2006)
J Exp Med
, vol.203
, pp. 269-273
-
-
Liu, Y.J.1
-
17
-
-
38849187386
-
IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation
-
DOI 10.1172/JCI33263
-
Ma HL, Liang S, Li J et al. (2008) IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 118:597-607 (Pubitemid 351206549)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.2
, pp. 597-607
-
-
Ma, H.-L.1
Liang, S.2
Li, J.3
Napierata, L.4
Brown, T.5
Benoit, S.6
Senices, M.7
Gill, D.8
Dunussi-Joannopoulos, K.9
Collins, M.10
Nickerson-Nutter, C.11
Fouser, L.A.12
Young, D.A.13
-
18
-
-
18244432009
-
Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
-
DOI 10.1016/S0092-8674(00)81168-X
-
Neubauer H, Cumano A, Muller M et al. (1998) Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 93:397-409 (Pubitemid 28232084)
-
(1998)
Cell
, vol.93
, Issue.3
, pp. 397-409
-
-
Neubauer, H.1
Cumano, A.2
Muller, M.3
Wu, H.4
Huffstadt, U.5
Pfeffer, K.6
-
19
-
-
0025831330
-
The cytokine network in psoriasis
-
Nickoloff BJ (1991) The cytokine network in psoriasis. Arch Dermatol 127:871-84
-
(1991)
Arch Dermatol
, vol.127
, pp. 871-884
-
-
Nickoloff, B.J.1
-
20
-
-
33847757147
-
Cracking the cytokine code in psoriasis
-
DOI 10.1038/nm0307-242, PII NM0307242
-
Nickoloff BJ (2007) Cracking the cytokine code in psoriasis. Nat Med 13:242-4 (Pubitemid 46376653)
-
(2007)
Nature Medicine
, vol.13
, Issue.3
, pp. 242-244
-
-
Nickoloff, B.J.1
-
21
-
-
36148992962
-
The cytokine and chemokine network in psoriasis
-
DOI 10.1016/j.clindermatol.2007.08.011, PII S0738081X07001551
-
Nickoloff BJ, Xin H, Nestle FO et al. (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25:568-73 (Pubitemid 350103656)
-
(2007)
Clinics in Dermatology
, vol.25
, Issue.6
, pp. 568-573
-
-
Nickoloff, B.J.1
Xin, H.2
Nestle, F.O.3
Qin, J.-Z.4
-
22
-
-
41549107522
-
Cytokine Signaling Modules in Inflammatory Responses
-
DOI 10.1016/j.immuni.2008.03.002, PII S1074761308001179
-
O'Shea JJ, Murray PJ (2008) Cytokine signaling modules in inflammatory responses. Immunity 28:477-87 (Pubitemid 351467044)
-
(2008)
Immunity
, vol.28
, Issue.4
, pp. 477-487
-
-
O'Shea, J.J.1
Murray, P.J.2
-
24
-
-
0026077199
-
New aspects of the mechanism of corticosteroid-induced dermal atrophy
-
Oikarinen A, Autio P (1991) New aspects of the mechanism of corticosteroid-induced dermal atrophy. Clin Exp Dermatol 16:416-9
-
(1991)
Clin Exp Dermatol
, vol.16
, pp. 416-419
-
-
Oikarinen, A.1
Autio, P.2
-
25
-
-
43449139402
-
Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
-
DOI 10.1016/S0140-6736(08)60726-6, PII S0140673608607266
-
Papp KA, Langley RG, Lebwohl M et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet 371:1675-84 (Pubitemid 351671884)
-
(2008)
The Lancet
, vol.371
, Issue.9625
, pp. 1675-1684
-
-
Papp, K.A.1
Langley, R.G.2
Lebwohl, M.3
Krueger, G.G.4
Szapary, P.5
Yeilding, N.6
Guzzo, C.7
Hsu, M.-C.8
Wang, Y.9
Li, S.10
Dooley, L.T.11
Reich, K.12
-
26
-
-
0032076542
-
Jak2 is essential for signaling through a variety of cytokine receptors
-
DOI 10.1016/S0092-8674(00)81167-8
-
Parganas E, Wang D, Stravopodis D et al. (1998) Jak2 is essential for signaling through a variety of cytokine receptors. Cell 93:385-95 (Pubitemid 28232083)
-
(1998)
Cell
, vol.93
, Issue.3
, pp. 385-395
-
-
Parganas, E.1
Wang, D.2
Stravopodis, D.3
Topham, D.J.4
Marine, J.-C.5
Teglund, S.6
Vanin, E.F.7
Bodner, S.8
Colamonici, O.R.9
Van Deursen, J.M.10
Grosveld, G.11
Ihle, J.N.12
-
27
-
-
47249157224
-
Therapeutic targeting of Janus kinases
-
DOI 10.1111/j.1600-065X.2008.00644.x
-
Pesu M, Laurence A, Kishore N et al. (2008) Therapeutic targeting of Janus kinases. Immunol Rev 223:132-42 (Pubitemid 351986189)
-
(2008)
Immunological Reviews
, vol.223
, Issue.1
, pp. 132-142
-
-
Pesu, M.1
Laurence, A.2
Kishore, N.3
Zwillich, S.H.4
Chan, G.5
O'Shea, J.J.6
-
28
-
-
77950684805
-
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: Therapeutic implications for the treatment of myeloproliferative neoplasms
-
Quintas-Cardama A, Vaddi K, Liu P et al. (2010) Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms. Blood 115:3109-17
-
(2010)
Blood
, vol.115
, pp. 3109-3117
-
-
Quintas-Cardama, A.1
Vaddi, K.2
Liu, P.3
-
29
-
-
13444269249
-
Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model
-
DOI 10.1038/nm1162
-
Sano S, Chan KS, Carbajal S et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9 (Pubitemid 40215836)
-
(2005)
Nature Medicine
, vol.11
, Issue.1
, pp. 43-49
-
-
Sano, S.1
Chan, K.S.2
Carbajal, S.3
Clifford, J.4
Peavey, M.5
Kiguchi, K.6
Itami, S.7
Nickoloff, B.J.8
DiGiovanni, J.9
-
30
-
-
39149102509
-
Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
-
DOI 10.1016/j.jdermsci.2007.05.016, PII S0923181107002095
-
Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin biology: a dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1-14 (Pubitemid 351249893)
-
(2008)
Journal of Dermatological Science
, vol.50
, Issue.1
, pp. 1-14
-
-
Sano, S.1
Chan, K.S.2
DiGiovanni, J.3
-
32
-
-
0242468041
-
Regulation of JAK-STAT signalling in the immune system
-
Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900-11 (Pubitemid 37411719)
-
(2003)
Nature Reviews Immunology
, vol.3
, Issue.11
, pp. 900-911
-
-
Shuai, K.1
Liu, B.2
-
33
-
-
0036301998
-
Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP
-
DOI 10.1038/ni805
-
Soumelis V, Reche PA, Kanzler H et al. (2002) Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673-80 (Pubitemid 34752477)
-
(2002)
Nature Immunology
, vol.3
, Issue.7
, pp. 673-680
-
-
Soumelis, V.1
Reche, P.A.2
Kanzler, H.3
Yuan, W.4
Edward, G.5
Homey, B.6
Gilliet, M.7
Ho, S.8
Antonenko, S.9
Lauerma, A.10
Smith, K.11
Gorman, D.12
Zurawski, S.13
Abrams, J.14
Menon, S.15
McClanahan, T.16
De Waal-Malefyt, R.17
Bazan, F.18
Kastelein, R.A.19
Liu, Y.-J.20
more..
-
34
-
-
52949089050
-
JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies
-
Vainchenker W, Dusa A, Constantinescu SN (2008) JAKs in pathology: role of Janus kinases in hematopoietic malignancies and immunodeficiencies. Semin Cell Dev Biol 19:385-93
-
(2008)
Semin Cell Dev Biol
, vol.19
, pp. 385-393
-
-
Vainchenker, W.1
Dusa, A.2
Constantinescu, S.N.3
-
35
-
-
77956696835
-
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis
-
Verstovsek S, Kantarjian H, Mesa RA et al. (2010) Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med 363:1117-27
-
(2010)
N Engl J Med
, vol.363
, pp. 1117-1127
-
-
Verstovsek, S.1
Kantarjian, H.2
Mesa, R.A.3
-
36
-
-
67651124902
-
The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis
-
Werfel T (2009) The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 129: 1878-91
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1878-1891
-
-
Werfel, T.1
-
37
-
-
62849108810
-
A randomized placebo-controlled study of INCB018424, a selective janus kinase 1&2 (JAK 1&2 inhibitor in rheumatoid arthritis (RA)
-
abstr
-
Williams W, Scherle P, Shi J et al. (2008) A randomized placebo-controlled study of INCB018424, a selective janus kinase 1&2 (JAK 1&2) inhibitor in rheumatoid arthritis (RA). Arthritis Rheum 58:S431(abstr
-
(2008)
Arthritis Rheum
, vol.58
-
-
Williams, W.1
Scherle, P.2
Shi, J.3
-
38
-
-
77749343026
-
Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function
-
Wohlmann A, Sebastian K, Borowski A et al. (2010) Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function. Biol Chem 391:181-6
-
(2010)
Biol Chem
, vol.391
, pp. 181-186
-
-
Wohlmann, A.1
Sebastian, K.2
Borowski, A.3
-
39
-
-
23944459169
-
Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin
-
DOI 10.1084/jem.20041503
-
Yoo J, Omori M, Gyarmati D et al. (2005) Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202:541-9 (Pubitemid 41186952)
-
(2005)
Journal of Experimental Medicine
, vol.202
, Issue.4
, pp. 541-549
-
-
Yoo, J.1
Omori, M.2
Gyarmati, D.3
Zhou, B.4
Aye, T.5
Brewer, A.6
Comeau, M.R.7
Campbell, D.J.8
Ziegler, S.F.9
-
40
-
-
33846906224
-
H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
-
DOI 10.1038/nature05505, PII NATURE05505
-
Zheng Y, Danilenko DM, Valdez P et al. (2007) Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648-51 (Pubitemid 46232884)
-
(2007)
Nature
, vol.445
, Issue.7128
, pp. 648-651
-
-
Zheng, Y.1
Danilenko, D.M.2
Valdez, P.3
Kasman, I.4
Eastham-Anderson, J.5
Wu, J.6
Ouyang, W.7
|